Key points are not available for this paper at this time.
Aims: Anti-TNF therapy used in patients with inflammatory bowel disease (IBD) has been associated with induction of autoantibodies including antinuclear antibodies (ANA), double strand (ds) DNA antibodies and the occurrence of lupus-like syndrome (LLS). However, the clinical relevance of autoantibody-formation and predictive factors are unclear.
Beigel et al. (Sun,) studied this question.